As of 2024-12-14, the Relative Valuation of Conmed Corp (CNMD) is 121.16 USD. This relative valuation is based on P/E multiples. With the latest stock price at 72.55 USD, the upside of Conmed Corp based on Relative Valuation is 67.0%.
The range of the Relative Valuation is 85.59 - 213.84 USD.
| Range | Selected | |
| Trailing P/E multiples | 27.6x - 50.1x | 34.7x |
| Forward P/E multiples | 27.0x - 32.7x | 29.8x |
| Fair Price | 85.59 - 213.84 | 121.16 |
| Upside | 18.0% - 194.7% | 67.0% |
| Date | P/E |
| 2024-12-11 | 17.19 |
| 2024-12-10 | 17.52 |
| 2024-12-09 | 17.51 |
| 2024-12-06 | 16.94 |
| 2024-12-05 | 17.02 |
| 2024-12-04 | 17.30 |
| 2024-12-03 | 17.57 |
| 2024-12-02 | 17.81 |
| 2024-11-29 | 17.36 |
| 2024-11-27 | 17.15 |
| 2024-11-26 | 17.33 |
| 2024-11-25 | 18.18 |
| 2024-11-22 | 17.56 |
| 2024-11-21 | 16.81 |
| 2024-11-20 | 16.58 |
| 2024-11-19 | 16.82 |
| 2024-11-18 | 16.59 |
| 2024-11-15 | 16.94 |
| 2024-11-14 | 16.69 |
| 2024-11-13 | 17.74 |
| 2024-11-12 | 17.53 |
| 2024-11-11 | 17.55 |
| 2024-11-08 | 17.22 |
| 2024-11-07 | 17.53 |
| 2024-11-06 | 17.74 |
| 2024-11-05 | 17.35 |
| 2024-11-04 | 16.52 |
| 2024-11-01 | 16.51 |
| 2024-10-31 | 16.00 |
| 2024-10-30 | 15.30 |
| 2024-10-29 | 15.17 |
| 2024-10-28 | 14.95 |
| 2024-10-25 | 14.57 |
| 2024-10-24 | 14.61 |
| 2024-10-23 | 14.61 |
| 2024-10-22 | 14.78 |
| 2024-10-21 | 14.97 |
| 2024-10-18 | 15.56 |
| 2024-10-17 | 15.18 |
| 2024-10-16 | 15.35 |
| 2024-10-15 | 15.20 |
| 2024-10-14 | 15.14 |
| 2024-10-11 | 15.01 |
| 2024-10-10 | 14.49 |
| 2024-10-09 | 14.77 |
| 2024-10-08 | 15.00 |
| 2024-10-07 | 15.02 |
| 2024-10-04 | 15.61 |
| 2024-10-03 | 15.61 |
| 2024-10-02 | 15.81 |